Youcare Pharmaceutical Group Co., Ltd. (SHA:688658)

SHA:688658 Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	2,535	3,767	4,183	4,521	4,942	4,241
Other Revenue	13.47	13.47	13.63	20.97	23.84	98.32
Revenue	2,548	3,781	4,196	4,542	4,966	4,339
Revenue Growth (YoY)	-39.77%	-9.90%	-7.61%	-8.53%	14.45%	1.20%
Cost of Revenue	1,344	1,640	1,622	1,669	1,556	1,504
Gross Profit	1,204	2,141	2,574	2,873	3,410	2,835
Selling, General & Admin	976.33	1,526	1,983	2,213	2,552	2,181
Research & Development	429.71	374.31	351.88	344.42	200.03	127.89
Other Operating Expenses	25.42	32.45	38.75	54.32	63.74	51.13
Operating Expenses	1,423	1,927	2,360	2,633	2,836	2,355
Operating Income	-218.89	213.69	214.88	240	574.2	480.25
Interest Expense	-21.78	-22.4	-13.21	-4.7	-3.47	-25.07
Interest & Investment Income	5.14	17.62	23.4	28.27	35.18	2.04
Currency Exchange Gain (Loss)	0.94	0.94	1.33	10.19	6.57	-13.05
Other Non Operating Income (Expenses)	-25.51	-38.64	-1.24	-1.08	-1.18	-3.5
EBT Excluding Unusual Items	-260.09	171.22	225.15	272.68	611.3	440.67
Gain (Loss) on Sale of Investments	2.65	2.34	-0.69	2.89	-	-
Gain (Loss) on Sale of Assets	1.22	-1.86	-2.77	-9.73	-5.27	-2.67
Asset Writedown	-18.72	-33.57	-21.78	-	-19.17	-
Other Unusual Items	14.23	14.23	23.36	83.68	42.41	57.13
Pretax Income	-260.72	152.36	223.27	349.53	629.27	495.14
Income Tax Expense	-19.17	31.11	35.77	10.62	85.55	51.51
Earnings From Continuing Operations	-241.56	121.25	187.49	338.91	543.72	443.63
Minority Interest in Earnings	7.57	2.47	-2.7	-3.72	1.59	-1.49
Net Income	-233.99	123.72	184.8	335.18	545.32	442.14
Net Income to Common	-233.99	123.72	184.8	335.18	545.32	442.14
Net Income Growth	-	-33.05%	-44.87%	-38.53%	23.34%	54.89%
Shares Outstanding (Basic)	443	442	451	453	451	359
Shares Outstanding (Diluted)	443	442	451	453	451	359
Shares Change (YoY)	-1.33%	-1.97%	-0.49%	0.51%	25.37%	-0.52%
EPS (Basic)	-0.53	0.28	0.41	0.74	1.21	1.23
EPS (Diluted)	-0.53	0.28	0.41	0.74	1.21	1.23
EPS Growth	-	-31.71%	-44.59%	-38.84%	-1.63%	55.70%
Free Cash Flow	-41.01	79.64	288.01	-669.13	314.75	570.94
Free Cash Flow Per Share	-0.09	0.18	0.64	-1.48	0.70	1.59
Dividend Per Share	-	-	0.200	1.100	0.680	0.450
Dividend Growth	-	-	-81.82%	61.77%	51.11%	-
Gross Margin	47.24%	56.62%	61.35%	63.25%	68.67%	65.34%
Operating Margin	-8.59%	5.65%	5.12%	5.28%	11.56%	11.07%
Profit Margin	-9.18%	3.27%	4.40%	7.38%	10.98%	10.19%
Free Cash Flow Margin	-1.61%	2.11%	6.86%	-14.73%	6.34%	13.16%
EBITDA	-2.06	409.65	383.01	394.15	709.47	611.88
EBITDA Margin	-0.08%	10.84%	9.13%	8.68%	14.29%	14.10%
D&A For EBITDA	216.83	195.96	168.13	154.15	135.28	131.64
EBIT	-218.89	213.69	214.88	240	574.2	480.25
EBIT Margin	-8.59%	5.65%	5.12%	5.28%	11.56%	11.07%
Effective Tax Rate	-	20.42%	16.02%	3.04%	13.59%	10.40%
Revenue as Reported	2,548	3,781	4,196	4,542	4,966	4,339
Advertising Expenses	-	4.75	14.7	18.36	-	0.53

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.